Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2001-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0968-0896(01)00228-0PMID 11711299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol 3-Sulfate Interferes with Cornified Envelope Assembly by Diverting Transglutaminase 1 Activity from the Formation of Cross-links and Esters to the Hydrolysis of Glutamine*

  2000cited by this paper
• A direct continuous spectrophotometric assay for transglutaminase activity.

  2000cited by this paper
• Guinea pig liver transglutaminase: A modified purification procedure affording enzyme with superior activity in greater yield.

  1999cited by this paper
• Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.

  1999cited by this paper
• Gaegurin 4, a peptide antibiotic of frog skin, forms voltage-dependent channels in planar lipid bilayers.

  1999cited by this paper
• Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register.

  1998cited by this paper
• A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminases.

  1998cited by this paper
• Controlled Regioselective Anilide Formation from Aspartic and Glutamic Acid Anhydrides

  1997cited by this paper
• Is transglutaminase the mediator between antimalarial drugs and psoriasis?

  1997cited by this paper
• Highly Active Soluble Processed Forms of the Transglutaminase 1 Enzyme in Epidermal Keratinocytes (*)

  1995cited by this paper
• Transglutaminases: Protein Cross-Linking Enzymes in Tissues and Body Fluids

  1994cited by this paper
• HIV‐1 gp120‐dependent induction of apoptosis in antigen‐specific human T cell clones is characterized by ‘tissue’ transglutaminase expression and prevented by cyclosporin A

  1994cited by this paper
• Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation.

  1994cited by this paper
• Solid-state 13C NMR study of a transglutaminase-inhibitor adduct.

  1993cited by this paper
• Irreversible inhibition of transglutaminases by sulfonium methylketones: optimization of specificity and potency with omega-aminoacyl spacers.

  1992cited by this paper
• Type I keratinocyte transglutaminase: expression in human skin and psoriasis.

  1992cited by this paper
• Peptides incorporating electrophilic glutamine analogues as potential transglutaminase inhibitors.

  1990cited by this paper
• Synthesis, chemistry, and absolute configuration of novel transglutaminase inhibitors containing a 3-halo-4,5-dihydroisoxazole

  1988cited by this paper
• Induction and activation of tissue transglutaminase during programmed cell death

  1987cited by this paper
• Synthesis of a novel class of peptides: dilactam-bridged tetrapeptides

  1987cited by this paper
• Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin

  1986cited by this paper
• Effects of solvents and additives on the reaction of N-benzyloxycarbonyl-L-aspartic anhydride with L-phenylalanine methyl ester (synthesis of aspartame)

  1986cited by this paper
• Specificity of activated human protein C.

  1985cited by this paper
• Development of selective inhibitors of transglutaminase. Phenylthiourea derivatives.

  1985cited by this paper
• Transglutaminases.

  1985cited by this paper
• Transglutaminase activity in human and rabbit ear comedogenesis: a histochemical study.

  1984cited by this paper
• Inflammation due to intra-cutaneous implantation of stratum corneum.

  1984cited by this paper
• Enhanced transglutaminase activity in transformed human lung fibroblast cells after exposure to sodium butyrate.

  1983cited by this paper
• Biological aspects of Alzheimer's disease

  1983cited by this paper
• Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

  1982cited by this paper
• Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.

  1982cited by this paper
• Transglutaminase activation: Significance with respect to immunologic phenomena

  1982cited by this paper
• Transglutaminase activity in normal and hereditary cataractous rat lens and its partial purification.

  1981cited by this paper
• Evidence for participation of transglutaminase in receptor-mediated endocytosis.

  1980cited by this paper
• Transglutaminase is essential in receptor-mediated endocytosis of α2-macroglobulin and polypeptide hormones

  1980cited by this paper
• Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions.

  1979cited by this paper
• The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases.

  1977cited by this paper
• The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases

  1977cited by this paper
• CORRELATIONS AMONG NUMBERS OF NEURITIC PLAQUES, NEUROFIBRILLARY TANGLES, AND THE SEVERITY OF SENILE DEMENTIA: 135

  1976cited by this paper
• Alkyl isocyanates as active site-directed inactivators of guinea pig liver transglutaminase.

  1975cited by this paper
• Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor.

  1974cited by this paper
• Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures.

  1974cited by this paper
• The amino acid sequence around the reactive cysteine residue in human plasma Factor XIII (Short Communication)

  1973cited by this paper
• The amino acid sequence around the reactive cysteine residue in human plasma Factor XII.

  1973cited by this paper
• FIBRINOLIGASE: THE FIBRIN‐STABILIZING FACTOR SYSTEM OF BLOOD PLASMA *

  1972cited by this paper
• Fibrin-stabilizing factor inhibitors. II. The inhibitory properties of various aliphatic amines.

  1971cited by this paper
• Cross-link in Fibrin Polymerized by Factor XIII: ε-(γ-Glutamyl)lysine

  1968cited by this paper
• The identification of isopeptide crosslinks in insoluble fibrin.

  1968cited by this paper
• Amine specificity in transpeptidation. Inhibition of fibrin cross-linking.

  1968cited by this paper
• [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine].

  1968cited by this paper
• Über 1.2.4-Thiodiazole, VIII. Synthese von 5-Chlor-1.2.4-Thiodiazolen aus Perchlormethylmercaptan und Amidinen

  1957cited by this paper

• The war on hTG2: warhead optimization in small molecule human tissue transglutaminase inhibitors.

  2023cites this paper
• Treatment of gluten-related disorders

  2022cites this paper
• Non-dietary therapies for celiac disease

  2022cites this paper
• Structure-activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors.

  2022cites this paper
• A copper-catalyzed approach for the synthesis of asymmetrical disubstituted 1,2,4-thiadiazoles via elemental sulfur-mediated decarboxylative redox cyclization

  2021cites this paper
• Transglutaminase 2 as a therapeutic target for neurological conditions

  2021cites this paper
• Transactions on Engineering Technologies: World Congress on Engineering and Computer Science 2018

  2020cites this paper
• Molecular Docking Analysis: Interaction Studies of Natural Compounds with Human TG2 Protein

  2020cites this paper
• Design, Synthesis and Evaluation of Covalent Inhibitors for Tissue Transglutaminase and Factor XIIIa

  2019cites this paper
• Evolving Therapy for Celiac Disease

  2019influential citation
• Procyanidin B2 rich cocoa extracts inhibit inflammation in Caco-2 cell model of in vitro celiac disease by down-regulating interferon-gamma- or gliadin peptide 31-43-induced transglutaminase-2 and interleukin-15

  2019cites this paper
• Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling.

  2018cites this paper
• 5-Amino-3-methyl-1,2,4-thiadiazole

  2018influential citation
• The Economic Burden of Gluten-Free Products and the Potential of Dietary Inhibitors of Transglutaminase-2

  2016cites this paper
• Structure-CaSR-Activity Relation of Kokumi γ-Glutamyl Peptides.

  2016cites this paper
• PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS

  2015cites this paper
• Therapeutic approaches for celiac disease.

  2015cites this paper
• Tissue Transglutaminase in Alzheimer's Disease: Involvement in Pathogenesis and its Potential as a Therapeutic Target

  2014cites this paper
• Abnormal blood clot formation induced by temperature responsive polymers by altered fibrin polymerization and platelet binding.

  2014cites this paper
• Celiac disease: the search for adjunctive or alternative therapies

  2014cites this paper
• Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors.

  2014cites this paper
• Tissue transglutaminase: an emerging target for therapy and imaging.

  2013cites this paper
• Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.

  2013cites this paper
• SUZUKI-MIYAURA COUPLING REACTIONS OF 3,5-DICHLORO-1,2,4-THIADIAZOLE.

  2012cites this paper
• Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.

  2012cites this paper
• Irreversible inhibitors of tissue transglutaminase.

  2011cites this paper
• Recent advances in the development of tissue transglutaminase (TG2) inhibitors

  2011cites this paper
• Novel therapies for coeliac disease

  2011cites this paper
• Cinnamic acid derivatives as anticancer agents-a review.

  2011cites this paper
• The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure.

  2010cites this paper
• Transglutaminase-catalyzed crosslinking in neurological disease: from experimental evidence to therapeutic inhibition.

  2010cites this paper
• Recent Progress in the Use of Vilsmeier-Type Reagents

  2010cites this paper
• Bioactive polymers : a comparative study on the antithrombotic properties of soluble polymers and surface grafted polymers

  2010cites this paper
• Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.

  2009cites this paper
• Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors.

  2009cites this paper
• Transglutaminase activation in neurodegenerative diseases.

  2009cites this paper
• An in situ and in vitro investigation for the transglutaminase potential in tissue engineering.

  2009cites this paper
• Cinnamoyl inhibitors of tissue transglutaminase.

  2008cites this paper
• Synthesis of potent water-soluble tissue transglutaminase inhibitors.

  2008cites this paper
• Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.

  2008cites this paper
• Reversible and Competitive Cinnamoyl Triazole Inhibitors of Tissue Transglutaminase

  2008cites this paper
• The bioorganic chemistry of transglutaminase — from mechanism to inhibition and engineering

  2008cites this paper
• Acyl transfer from carboxylate, carbonate, and thiocarbonate esters to enzymatic and nonenzymatic thiolates

  2007cites this paper
• Transglutaminase 2 inhibitors and their therapeutic role in disease states.

  2007cites this paper
• Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

  2007cites this paper
• Synthesis and evaluation of peptidic maleimides as transglutaminase inhibitors.

  2007cites this paper
• New therapeutic strategies for coeliac disease: tissue transglutaminase as a target.

  2007cites this paper
• Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells.

  2007cites this paper
• Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.

  2007cites this paper
• Advances in the synthesis and recent therapeutic applications of 1,2,4-thiadiazole heterocycles.

  2006cites this paper
• Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase.

  2006cites this paper
• Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.

  2006cites this paper
• Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides.

  2006cites this paper
• Tissue transglutaminase inhibition.

  2005cites this paper
• Transglutaminases as targets for pharmacological inhibition.

  2005cites this paper
• 3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors.

  2005cites this paper
• Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.

  2005cites this paper
• Synthesis and biological evaluation of a new series of 2,3,5-substituted [1,2,4]-thiadiazoles as modulators of adenosine A1 receptors and their molecular mechanism of action.

  2005cites this paper
• Synthesis of 3-substituted bicyclic imidazo[1,2-d][1,2,4]thiadiazoles and tricyclic benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazoles.

  2005cites this paper
• Medicinal chemistry and properties of 1,2,4-thiadiazoles.

  2005cites this paper
• Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase.

  2003cites this paper
• 1,2,4-thiadiazole: a novel Cathepsin B inhibitor.

  2003cites this paper
• Thiol-dependent enzymes and their inhibitors: a review.

  2002cites this paper